Similar articles for PMID: 16849374

Year	Number of Results
2000	3
2001	1
2002	5
2003	5
2004	10
2005	19
2006	34
2007	18
2008	14
2009	12
2010	5
2011	7
2012	7
2013	8
2014	7
2015	5
2016	1
2017	8
2018	5
2019	3
2020	3
2024	0

1

The coronary risk of cyclo-oxygenase-2 inhibitors in patients with a previous myocardial infarction.

Brophy JM, Lévesque LE, Zhang B. Brophy JM, et al. Heart. 2007 Feb;93(2):189-94. doi: 10.1136/hrt.2006.089367. Epub 2006 Jul 18. Heart. 2007. PMID: 16849374 Free PMC article.

2

Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.

Johnsen SP, Larsson H, Tarone RE, McLaughlin JK, Nørgård B, Friis S, Sørensen HT. Johnsen SP, et al. Arch Intern Med. 2005 May 9;165(9):978-84. doi: 10.1001/archinte.165.9.978. Arch Intern Med. 2005. PMID: 15883235

3

Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.

Moride Y, Ducruet T, Boivin JF, Moore N, Perreault S, Zhao S. Moride Y, et al. Arthritis Res Ther. 2005;7(2):R333-42. doi: 10.1186/ar1488. Epub 2005 Jan 17. Arthritis Res Ther. 2005. PMID: 15743481 Free PMC article.

4

Association between nonnaproxen NSAIDs, COX-2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study.

Rahme E, Watson DJ, Kong SX, Toubouti Y, LeLorier J. Rahme E, et al. Pharmacoepidemiol Drug Saf. 2007 May;16(5):493-503. doi: 10.1002/pds.1339. Pharmacoepidemiol Drug Saf. 2007. PMID: 17086567

5

Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.

Gislason GH, Jacobsen S, Rasmussen JN, Rasmussen S, Buch P, Friberg J, Schramm TK, Abildstrom SZ, Køber L, Madsen M, Torp-Pedersen C. Gislason GH, et al. Circulation. 2006 Jun 27;113(25):2906-13. doi: 10.1161/CIRCULATIONAHA.106.616219. Epub 2006 Jun 19. Circulation. 2006. PMID: 16785336 Free article.

6

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults.

Solomon DH, Schneeweiss S, Glynn RJ, Kiyota Y, Levin R, Mogun H, Avorn J. Solomon DH, et al. Circulation. 2004 May 4;109(17):2068-73. doi: 10.1161/01.CIR.0000127578.21885.3E. Epub 2004 Apr 19. Circulation. 2004. PMID: 15096449

7

Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitors.

Lévesque LE, Brophy JM, Zhang B. Lévesque LE, et al. CMAJ. 2006 May 23;174(11):1563-9. doi: 10.1503/cmaj.051679. Epub 2006 May 2. CMAJ. 2006. PMID: 16670396 Free PMC article.

8

Factors associated with celecoxib and rofecoxib utilization.

Rawson NS, Nourjah P, Grosser SC, Graham DJ. Rawson NS, et al. Ann Pharmacother. 2005 Apr;39(4):597-602. doi: 10.1345/aph.1E298. Epub 2005 Mar 8. Ann Pharmacother. 2005. PMID: 15755796

9

Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.

Rahme E, Nedjar H. Rahme E, et al. Rheumatology (Oxford). 2007 Mar;46(3):435-8. doi: 10.1093/rheumatology/kel428. Epub 2007 Jan 25. Rheumatology (Oxford). 2007. PMID: 17255138

10

Thromboembolic cardiovascular risk among arthritis patients using cyclooxygenase-2-selective inhibitor or nonselective cyclooxygenase inhibitor nonsteroidal anti-inflammatory drugs.

Spalding WM, Reeves MJ, Whelton A. Spalding WM, et al. Am J Ther. 2007 Jan-Feb;14(1):3-12. doi: 10.1097/01.pap.0000249930.01907.db. Am J Ther. 2007. PMID: 17303969

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

169 results

Results by year